Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Regents of the University of Minnesota”

446 pharma patents match "Regents of the University of Minnesota" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 446
Index total 30,257
Page 12 / 19

Quick answer

This filtered view shows 446 pharmaceutical patents matching "Regents of the University of Minnesota" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

446 results for “Regents of the University of Minnesota” · 30,257 patents in full index Clear search

  1. US 8933193

    Lantibiotics and uses thereof

    Regents of the University of Minnesota · Granted Jan 13, 2015 · Expires Jan 8, 2035

    granted

  2. US 8911743

    Haemophilus parasuis polypeptides and methods of use

    Regents of the University of Minnesota · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  3. US 8845801

    Bone cement and method

    Regents of the University of Minnesota · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted

  4. US 8815830

    Nucleosides with antiviral and anticancer activity

    Regents of the University of Minnesota · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted

  5. US 8809016

    Nucleic acids encoding modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

  6. US 8796332

    Compositions and methods for controlling infections

    Regents of the University of Minnesota · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted

  7. US 8765935

    Nucleosides with antiviral and anticancer activity

    Regents of the University of Minnesota · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted

  8. US 8734836

    Methods and compositions for applying pharmacologic agents to the ear

    Regents of the University of Minnesota · Granted May 27, 2014 · Expires May 22, 2034

    granted

  9. US 8728532

    Ischemia/reperfusion protection compositions and methods of using

    Regents of the University of Minnesota · Granted May 20, 2014 · Expires May 15, 2034

    granted

  10. US 8716343

    Calixarene-based peptide conformation mimetics, methods of use, and methods of making

    Regents of the University of Minnesota · Granted May 6, 2014 · Expires May 1, 2034

    granted

  11. US 8697853

    TAL effector-mediated DNA modification

    Regents of the University of Minnesota · Granted Apr 15, 2014 · Expires Apr 10, 2034

    granted

  12. US 8642738

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  13. US 8642550

    Chimeric natriuretic peptides without hypotensive inducing capability

    Regents of the University of Minnesota · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  14. US 8642656

    Calixarene-based peptide conformation mimetics, methods of use, and methods of making

    Regents of the University of Minnesota · Granted Feb 4, 2014 · Expires Jan 30, 2034

    granted

  15. US 8628769

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Jan 14, 2014 · Expires Jan 9, 2034

    granted

  16. US 8623841

    Medical and nutritional applications of highly refined cellulose

    Regents of the University of Minnesota · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  17. US 8617132

    Bioresorbable embolization microspheres

    Regents of the University of Minnesota · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  18. US 8609412

    Mapc generation of lung tissue

    Regents of the University of Minnesota · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  19. US 8609088

    Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases

    Regents of the University of Minnesota · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  20. US 8609682

    Analgesic agents

    Regents of the University of Minnesota · Granted Dec 17, 2013 · Expires Dec 12, 2033

    granted

  21. US 8586363

    TAL effector-mediated DNA modification

    Regents of the University of Minnesota · Granted Nov 19, 2013 · Expires Nov 14, 2033

    granted

  22. US 8580249

    Cell therapy for the treatment of lysosomal storage disorders

    Regents of the University of Minnesota · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted

  23. US 8580921

    Protein nanorings

    Regents of the University of Minnesota · Granted Nov 12, 2013 · Expires Nov 7, 2033

    granted

  24. US 8563001

    Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease

    Regents of the University of Minnesota · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.